Board Certified New York Plastic Surgeon, David. P. Rapaport, son of holocaust survivors, began the study of medicine at Boston University six-year medical program at age 16 before transferring to Israel’s Tel Aviv University, where he earned his medical degree. He trained in general surgery at Boston’s Beth Israel Hospital, a major teaching hospital of Harvard Medical School, where he served as Chief Resident. He then did his plastic surgery training at the New York University’s Institute of Reconstructive Plastic Surgery, which is widely regarded as the nation’s top plastic and cosmetic surgery residency program. There too, he was appointed Executive Chief Resident. After a one-year microsurgery fellowship, Dr. Rapaport moved to Florida, where from 1993 to 1997, he was a key faculty member at the University of South Florida. There, he developed a successful and respected practice as a cosmetic plastic surgeon. During his four years in Florida, he also helped craft legislation requiring broader insurance coverage for reconstructive breast surgery, directed the cosmetic surgery education of residents, and did pioneering work in endoscopic and minimal incision breast and oncologic (melanoma) surgery. In 1997, he returned to New York City and opened his private cosmetic surgery practice in Manhattan, New York.
Dr. Rapaport specializes in New York Breast Augmentation, Liposuction, and Coolsculpting. All of Dr. Rapaport’s procedures are performed on-site in his fully accredited office surgical suite on Fifth Avenue in Manhattan, New York. Dr. Rapaport also offers cosmetic and non-surgical procedures such as injectable fillers, Botox, earlobe repair, mole removal, and more. Many of these procedures require no down-time.
Held: 1985-1990 Resident, Plastic Surgery
1990-1992 Resident, Plastic Surgery
1992-1993 Fellowship, Microsurgery
1993-1997 Assistant Professor
1998-Present Private Practice
Six – Year Medical Program
Tel Aviv University
School of Medicine
Ramat Aviv, Israel
Doctor of Medicine
Work with Lockhead Martin and Neoprobe Corporation to develop improved (miniaturized) gamma detectors for sentinel node biopsy. Co-Director of training sessions on sentinel lymphadenectomy techniques. Courses given several times each year (since 1995) are attended by U.S. and international surgeons.
Development of and instruction in technique for endoscopically harvesting the saphenous vein for coronary artery bypass graft (CABG) surgery. Principal Investigator in prospective study comparing open versus closed saphenous harvest techniques. Developed new minimal incision technique for groin dissection in malignant melanoma. Original technique published in Balch’s Cutaneous Melanoma, see Chapters below. Development of a model for fat necrosis in the Zucker (fat) rat.
Stadelmann W, Rapapot DP, Reintgen DS. Prognostic factors in melanoma.
Balch, Cutaneous Melanoma: 3rd edition, 1998.
Rapaport DP, Stadelmann W, Reintgen DS. Groin dissection.
Balch, Cutaneous Melanoma: 3rd edition, 1998.
Ziv P. Rapaport DP, Dinstman M: Primary hyperparathyroidism associated with panctyosis. New England Journal of Medicine 313(3), 187, 1985.
Rapaport DP, Ziv Y, Rubin M, Huminer D, Dinstman M: Primary hyperthyroidism in children. Journal of Pediatric Surgery 21 (5); 395-397, 1986.
Rapaport DP, Breitbart AS, Karp NS, Siebert JW: Successful microvascular replantation of a completely amputated ear. Microsurgery 14; 312-314, 1993.
Mogilner A, Grossman JAI, Ribary U, Joliot M, Volkmann J, Rapaport DP, Beasley RW, Llinas RR: Somatosensory cortical plasticity in adult humans revealed by magnetoencephalography. Proceedings National Academy of Science 90: 3593-3597, 1993.
Wang X, Heller R, Cruse CW, VanVoorhis N, Glass F, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220; 769-774, 1994.
Reintgen D, Albertini F, Miliotes SB, Berman C, Cruse CW, Fenske N, Glass F, Puleo C, Wang X, Wells KE, Rapaport DP, DeConti R, Messina J, Heller R: The accurate staging and modern day treatment of malignant melanoma. Can Res, Therapy and Control 4; 183-197, 1995.
Rapaport DP, Bass LS, Aston SJ: Influence of steroids on post-operative swelling after facioplasty: A prospective randomized study. Plastic Reconstructive Surgery 96 (7); 1547-1552, 1995.
Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II Trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Canc 77 (5); 964-971, 1996.
Albertini JJ, Cruse CW, Rapaport DP, Wells K, Ross M, DeConti R, Bermann CG, Jared K, Messina J, Lyman G, Glss F, Fenske N, Reintgen DS. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223 (2); 217-224, 1996.
Rapaport DP, Stadelmann WK, Greenwald DP. Incidence and natural history of saline-filled breast implant deflations: Comparison of blunt-tipped versus cutting and tapered needles. Plastic Reconstructive Surgery 100: 1028-1032, 1997.
Stadelmann WK, Rapaport DP, Payne W, Shons AR, Krizek TK. Residency training in aesthetic surgery: maximizing the residents’ experience. Plastic Reconstructive Surgery 101;1973-1977, 1998.
Wells, K.E., Stadelmann, W.K., Rapaport, D.P., Hamlin, R., Cruse CW, Reintgen DS: Parotid Selective Lymphadenectomy in Malignant Melanoma, Annals of Plastic Surgery, 1999;43:1-6.
Payne W, Curse CW, Rapaport D, Wells K, Daniels S, Reintgen DS. Selective lymphadenectomy: Sentinel node biopsy in head and neck melanoma, Amer Soc of Plast and Recon Surg, 1994.
Albertini J, Milliotes G, Cruse CW, DeConti R, Rapaport D, Berman C, Glass F, Fenske N, Reintgen DS. Quality and cost outcome measurement in melanoma surgical care. Soc of Surg Oncol, Boston, 1994.
Wells K, Cruse CW, Rapaport DP, Payne W, Petsoglou C, Reintgen DS, Sentinel lymph node biopsy in melanoma of the head and neck. Amer Soc of Plast and Recon Surg, 1995.
Rapaport DP, Albertini J, Cruse CW, et, Al.: Identification of the sentinel node in melanoma patients using radiolymphoscintigraphy and vital blue dye. 18th Ann Sem of Canc Res in FL, Amer Canc Soc, FL Div, Orlando, Mar 1995.
Albertini J, Cruse CW, Rapaport DP, Wells K, DeConti R, Lyman G, Glass F, Messina J, Berman C, Jared K, Reintgen D. Identification of the sentinel node in melanoma patients using radiolymphoscintigraphy and vital blue dye injection. Amer Soc of Plast and Recon Surg, 1995.
Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 65th An Sci Mtg. Dallas, TX., 1996.
Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 66th An Sci Mtg. San Francisco, CA., 1997.
Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 67th An Sci Mtg. Boston, MA., 1998.
Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 68th An Sci Mtg. New Orleans, LA., 1999.
By submitting this consultation form you consent to be contacted via phone/text or email.
We are excited to announce that as of June 8th, 2020, our office will be open for ALL appointment types including Surgery, Cosmetic Injectables, Earlobe Repairs, Mole Removals, CoolSculpting, CoolTone, Morpheus8, miraDry, Skincare services, and more!
During this time, we are still encouraging virtual consultations & follows up as an initial step prior to an in-person appointment. We are requesting that established patients virtually consult/review their treatment plans with Dr. Rapaport or a medical aesthetician in advance of their scheduled treatments/procedures. We will be providing you with specific procedure-related instructions prior upon scheduling. If you left a deposit for a treatment and have not yet been contacted by our staff, please call, or e-mail our office so that we may get you scheduled.
Dr. Rapaport & his team have been working diligently to get our office prepared for our re-opening. Our main priority is the health and safety of our patients and staff. Thank you for following our guidelines and being so patient. See below for our re-opening guidelines:
For any questions and/or concerns, please call our office at 212-249-9955 or email us at office@DrRapaport.com. We know each of you are eager to get back to your treatment regimens, so we will be extending our hours to accommodate everyone as best we can while maintaining health & safety protocols!
We thank you for your continued support & confidence in Dr. Rapaport and our staff the past few months. We look forward to welcoming you back to our office!